https://youtu.be/2ucSbVeq3V4Good news ! Emilie Faggiani, who leads the cell therapy programme for Parkinson’s disease at TreeFrog, was selected to talk at the 30th Annual Meeting of NECTAR. The conference, which brings together world-class experts in the field of cell therapies for neurodegenerative diseases, will take place...

We’re glad to invite you to the first webinar held by TreeFrog Therapeutics on November 18, at 10 am (EST): Scaling-up iPS-derived cell therapy productionwhile preserving cell quality In this webinar, Kevin Alessandri, our CEO & co-founder, will present data showing that: C-Stem enables >100x hPSC expansion per week...

Today, Andrea Leonoard, Senior Scientist at TreeFrog Therapeutics was in London, UK to speak at the 3D Cell Culture Conference. She gave an invited presentation about the C-Stem™, our 3D technology for stem cell mass-production....

Today, Maxime Feyeux, President and CSO of TreeFrog Therapeutics, presented the C-Stem™ technology at the Regenerative Medicine Crossroad in Tokyo #11 conference!...

TreeFrog Therapeutics’ CEO/CTO, Kevin Alessandri is spending a week in Boston (Novembre 4-9) as part of the New Technology Venture Accelerator (NETVA) program to meet the local deep tech ecosystem.Thanks to the teams of the Science and Technology Department of the French Embassy in the United States who...

TreeFrog Therapeutics was Japan from the 10th to 21th of September 2019 to meet key academic and industry players. Notably, our team gave a presentation at the mecca of iPS : the Center for iPS Cell Research and Application (CiRA), Kyoto University. And on September 18th, Maxime Feyeux,...

TreeFrog will be in Japan from the 10th to 21th of September 2019 to meet key academic and industry players ! This cell therapy roadtrip, organized with the help of Business France, will be marked by our participation to Cell Therapy Word Asia 2019 on Sept 18-19 !...